[Amyotrophic lateral sclerosis and respiratory insufficiency]

Area of Science:

• Neurology
• Pulmonology
• Respiratory Medicine

Context:

• Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease.
• Respiratory muscle atrophy is the primary cause of mortality in ALS patients.
• ALS-associated respiratory insufficiency presents unique challenges distinct from cardiac or pulmonary dyspnea.

Purpose:

• To highlight the distinct mechanisms of respiratory insufficiency in ALS.
• To emphasize the importance of early recognition and prediction of respiratory decline.
• To advocate for noninvasive ventilatory support as a primary treatment modality.

Summary:

• ALS leads to motor neuron degeneration, culminating in respiratory muscle atrophy and failure.
• Early identification of respiratory insufficiency in ALS is crucial for timely intervention.
• Noninvasive ventilatory support is the recommended first-line treatment for managing dyspnea in ALS patients.

Impact:

• Improved clinical recognition and management of respiratory complications in ALS.
• Enhanced patient outcomes through proactive respiratory support.
• Reduced emergency interventions by enabling preemptive treatment strategies.